

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 9.76438498 |
| 2 | muscle filament sliding (GO:0030049) | 9.76438498 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 8.96601478 |
| 4 | sarcomere organization (GO:0045214) | 8.66260774 |
| 5 | actin-mediated cell contraction (GO:0070252) | 8.03113520 |
| 6 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.48422068 |
| 7 | myofibril assembly (GO:0030239) | 7.47867434 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.23776856 |
| 9 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.99295159 |
| 10 | cardiac myofibril assembly (GO:0055003) | 6.98750695 |
| 11 | plasma membrane repair (GO:0001778) | 6.93230092 |
| 12 | skeletal muscle contraction (GO:0003009) | 6.78878264 |
| 13 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.69046471 |
| 14 | striated muscle contraction (GO:0006941) | 6.24519754 |
| 15 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.22332056 |
| 16 | cardiac muscle contraction (GO:0060048) | 6.12185956 |
| 17 | actin filament-based movement (GO:0030048) | 6.00220493 |
| 18 | skeletal muscle adaptation (GO:0043501) | 5.77832601 |
| 19 | carnitine shuttle (GO:0006853) | 5.73234565 |
| 20 | tricarboxylic acid cycle (GO:0006099) | 5.68462612 |
| 21 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.66856633 |
| 22 | actomyosin structure organization (GO:0031032) | 5.64134017 |
| 23 | regulation of relaxation of muscle (GO:1901077) | 5.63068090 |
| 24 | regulation of cell communication by electrical coupling (GO:0010649) | 5.56318581 |
| 25 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.42610152 |
| 26 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.41399506 |
| 27 | regulation of actin filament-based movement (GO:1903115) | 5.41091850 |
| 28 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.39428999 |
| 29 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.38126992 |
| 30 | cardiac muscle cell development (GO:0055013) | 5.28030580 |
| 31 | creatine metabolic process (GO:0006600) | 5.14225868 |
| 32 | cardiac cell development (GO:0055006) | 4.95048077 |
| 33 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.91553266 |
| 34 | skeletal muscle tissue development (GO:0007519) | 4.90912812 |
| 35 | fatty acid transmembrane transport (GO:1902001) | 4.88307303 |
| 36 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.75821056 |
| 37 | regulation of striated muscle contraction (GO:0006942) | 4.66768184 |
| 38 | muscle contraction (GO:0006936) | 4.58277624 |
| 39 | response to inactivity (GO:0014854) | 4.54271088 |
| 40 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.53654188 |
| 41 | cardiac muscle hypertrophy (GO:0003300) | 4.53065843 |
| 42 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.51887688 |
| 43 | adult heart development (GO:0007512) | 4.51808368 |
| 44 | regulation of coenzyme metabolic process (GO:0051196) | 4.50099637 |
| 45 | regulation of cofactor metabolic process (GO:0051193) | 4.50099637 |
| 46 | striated muscle hypertrophy (GO:0014897) | 4.46111271 |
| 47 | heart contraction (GO:0060047) | 4.38993087 |
| 48 | heart process (GO:0003015) | 4.38993087 |
| 49 | regulation of sarcomere organization (GO:0060297) | 4.38548413 |
| 50 | regulation of membrane repolarization (GO:0060306) | 4.37559001 |
| 51 | response to muscle activity (GO:0014850) | 4.26929901 |
| 52 | striated muscle adaptation (GO:0014888) | 4.26303119 |
| 53 | muscle tissue morphogenesis (GO:0060415) | 4.25608577 |
| 54 | carnitine transmembrane transport (GO:1902603) | 4.23556278 |
| 55 | muscle system process (GO:0003012) | 4.20799193 |
| 56 | fructose metabolic process (GO:0006000) | 4.17323294 |
| 57 | striated muscle atrophy (GO:0014891) | 4.10202966 |
| 58 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.09430977 |
| 59 | * glucan catabolic process (GO:0009251) | 4.07470172 |
| 60 | muscle cell fate commitment (GO:0042693) | 4.02571510 |
| 61 | muscle organ morphogenesis (GO:0048644) | 4.01933730 |
| 62 | muscle structure development (GO:0061061) | 4.01410012 |
| 63 | muscle organ development (GO:0007517) | 4.00603727 |
| 64 | response to activity (GO:0014823) | 3.99646103 |
| 65 | positive regulation of myotube differentiation (GO:0010831) | 3.97709095 |
| 66 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.96815007 |
| 67 | heart trabecula formation (GO:0060347) | 3.93596779 |
| 68 | muscle hypertrophy (GO:0014896) | 3.92670829 |
| 69 | gluconeogenesis (GO:0006094) | 3.85709090 |
| 70 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.85435217 |
| 71 | striated muscle cell development (GO:0055002) | 3.84765571 |
| 72 | amino-acid betaine transport (GO:0015838) | 3.84740988 |
| 73 | carnitine transport (GO:0015879) | 3.84740988 |
| 74 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.84196832 |
| 75 | muscle fiber development (GO:0048747) | 3.82504106 |
| 76 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.82268251 |
| 77 | * cellular polysaccharide catabolic process (GO:0044247) | 3.80408956 |
| 78 | cytidine metabolic process (GO:0046087) | 3.77738259 |
| 79 | cytidine catabolic process (GO:0006216) | 3.77738259 |
| 80 | cytidine deamination (GO:0009972) | 3.77738259 |
| 81 | skeletal muscle fiber development (GO:0048741) | 3.75764068 |
| 82 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.74498382 |
| 83 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.74498382 |
| 84 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.73742721 |
| 85 | NADH metabolic process (GO:0006734) | 3.69796484 |
| 86 | skeletal muscle tissue regeneration (GO:0043403) | 3.67003928 |
| 87 | * glycogen metabolic process (GO:0005977) | 3.66917747 |
| 88 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.64968606 |
| 89 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.63253326 |
| 90 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.63253326 |
| 91 | myoblast fusion (GO:0007520) | 3.61985718 |
| 92 | regulation of sulfur metabolic process (GO:0042762) | 3.61886903 |
| 93 | 2-oxoglutarate metabolic process (GO:0006103) | 3.61845826 |
| 94 | cell communication involved in cardiac conduction (GO:0086065) | 3.60641179 |
| 95 | glucan biosynthetic process (GO:0009250) | 3.60471933 |
| 96 | glycogen biosynthetic process (GO:0005978) | 3.60471933 |
| 97 | * cellular glucan metabolic process (GO:0006073) | 3.59570410 |
| 98 | * glucan metabolic process (GO:0044042) | 3.59570410 |
| 99 | neuronal action potential propagation (GO:0019227) | 3.59274827 |
| 100 | negative regulation of muscle contraction (GO:0045932) | 3.52419664 |
| 101 | muscle adaptation (GO:0043500) | 3.51802439 |
| 102 | muscle atrophy (GO:0014889) | 3.49400609 |
| 103 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.49255635 |
| 104 | cardiac muscle cell action potential (GO:0086001) | 3.48896922 |
| 105 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.48611019 |
| 106 | cardiac muscle adaptation (GO:0014887) | 3.48586371 |
| 107 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.48586371 |
| 108 | muscle hypertrophy in response to stress (GO:0003299) | 3.48586371 |
| 109 | regulation of the force of heart contraction (GO:0002026) | 3.48307260 |
| 110 | negative regulation of potassium ion transport (GO:0043267) | 3.47036046 |
| 111 | positive regulation of cation channel activity (GO:2001259) | 3.46671118 |
| 112 | IMP metabolic process (GO:0046040) | 3.46188344 |
| 113 | negative regulation of protein localization to cell surface (GO:2000009) | 3.45880121 |
| 114 | hexose biosynthetic process (GO:0019319) | 3.44048574 |
| 115 | myotube differentiation (GO:0014902) | 3.43871015 |
| 116 | * polysaccharide catabolic process (GO:0000272) | 3.40134882 |
| 117 | negative regulation of muscle hypertrophy (GO:0014741) | 3.37271819 |
| 118 | regulation of sequestering of triglyceride (GO:0010889) | 3.36404107 |
| 119 | oxidative phosphorylation (GO:0006119) | 3.35915771 |
| 120 | ubiquinone biosynthetic process (GO:0006744) | 3.35666451 |
| 121 | striated muscle tissue development (GO:0014706) | 3.35631436 |
| 122 | relaxation of muscle (GO:0090075) | 3.35619996 |
| 123 | muscle cell cellular homeostasis (GO:0046716) | 3.34782795 |
| 124 | regulation of myoblast differentiation (GO:0045661) | 3.34464524 |
| 125 | regulation of ATP catabolic process (GO:1903289) | 3.32929421 |
| 126 | regulation of ATPase activity (GO:0043462) | 3.32929421 |
| 127 | regulation of muscle contraction (GO:0006937) | 3.31448058 |
| 128 | * glycogen catabolic process (GO:0005980) | 3.30300511 |
| 129 | muscle cell development (GO:0055001) | 3.28780450 |
| 130 | myotube cell development (GO:0014904) | 3.26577595 |
| 131 | neuromuscular synaptic transmission (GO:0007274) | 3.23198460 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.78473575 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.62509822 |
| 3 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.69861564 |
| 4 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.59532329 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.53494713 |
| 6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.51837481 |
| 7 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.51837481 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.28561853 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.89935461 |
| 10 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.56251138 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.53430289 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.33122502 |
| 13 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.28971067 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.22871188 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.20561978 |
| 16 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.17860208 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.16568945 |
| 18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.12802986 |
| 19 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.84359987 |
| 20 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.75960251 |
| 21 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.71443438 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68498113 |
| 23 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.66070061 |
| 24 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.62441812 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.56238199 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.55962247 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52148275 |
| 28 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.49967100 |
| 29 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.49242383 |
| 30 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.47181998 |
| 31 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.47153059 |
| 32 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.43043351 |
| 33 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.37082835 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.36781343 |
| 35 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.35099735 |
| 36 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.30320430 |
| 37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30286786 |
| 38 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30178662 |
| 39 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.30083237 |
| 40 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.26930584 |
| 41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24069398 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.22363460 |
| 43 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.21799556 |
| 44 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18780202 |
| 45 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18765609 |
| 46 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15612174 |
| 47 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.15522850 |
| 48 | P68_20966046_ChIP-Seq_HELA_Human | 1.14266742 |
| 49 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.13851745 |
| 50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.10904609 |
| 51 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10567841 |
| 52 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.10503439 |
| 53 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.09648477 |
| 54 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.08613127 |
| 55 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.08492101 |
| 56 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.07603608 |
| 57 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.06720875 |
| 58 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.06578618 |
| 59 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.06082365 |
| 60 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.06043720 |
| 61 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05880405 |
| 62 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.05459150 |
| 63 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.05135967 |
| 64 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05075819 |
| 65 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.04928100 |
| 66 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04861591 |
| 67 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.04462125 |
| 68 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.03613233 |
| 69 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.03602556 |
| 70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.03311513 |
| 71 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03178565 |
| 72 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02972852 |
| 73 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.02069980 |
| 74 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.00616343 |
| 75 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.99569652 |
| 76 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.99548454 |
| 77 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97465664 |
| 78 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.97425049 |
| 79 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.96597604 |
| 80 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.94276541 |
| 81 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.94206391 |
| 82 | SA1_27219007_Chip-Seq_Bcells_Human | 0.93713360 |
| 83 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.93690273 |
| 84 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.93293729 |
| 85 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93183438 |
| 86 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.92377692 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92098235 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91046814 |
| 89 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.90802462 |
| 90 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.90437169 |
| 91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89988695 |
| 92 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.89952491 |
| 93 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88950706 |
| 94 | ATF3_27146783_Chip-Seq_COLON_Human | 0.88944027 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88454763 |
| 96 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.88358762 |
| 97 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88320596 |
| 98 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88310942 |
| 99 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.87747571 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.87300246 |
| 101 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.86948008 |
| 102 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.86514549 |
| 103 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.86514549 |
| 104 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.86280522 |
| 105 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86041848 |
| 106 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85893230 |
| 107 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.85772513 |
| 108 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.85545673 |
| 109 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.85432607 |
| 110 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85239363 |
| 111 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.84619891 |
| 112 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.84388508 |
| 113 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.83991226 |
| 114 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83935259 |
| 115 | CJUN_26792858_Chip-Seq_BT549_Human | 0.82276191 |
| 116 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.80996041 |
| 117 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.80676140 |
| 118 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.80662525 |
| 119 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80352578 |
| 120 | GATA1_22025678_ChIP-Seq_K562_Human | 0.80326295 |
| 121 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.80215389 |
| 122 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.79990894 |
| 123 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.79424986 |
| 124 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.79315692 |
| 125 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.79048571 |
| 126 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78902430 |
| 127 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.78774825 |
| 128 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77240726 |
| 129 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77240726 |
| 130 | VDR_22108803_ChIP-Seq_LS180_Human | 0.76890611 |
| 131 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.76559380 |
| 132 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.75708586 |
| 133 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74369648 |
| 134 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.74346072 |
| 135 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.73068549 |
| 136 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.72944611 |
| 137 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.72635236 |
| 138 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.72520566 |
| 139 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.72520566 |
| 140 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.71602426 |
| 141 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.71165906 |
| 142 | * STAT1_20625510_ChIP-Seq_HELA_Human | 0.71096322 |
| 143 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.70134851 |
| 144 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.69181411 |
| 145 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.68809906 |
| 146 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.68690431 |
| 147 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.68537015 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 6.32247828 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.88330357 |
| 3 | MP0000751_myopathy | 5.71522639 |
| 4 | MP0000749_muscle_degeneration | 5.15317857 |
| 5 | MP0004145_abnormal_muscle_electrophysio | 4.70729625 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.48979459 |
| 7 | MP0004084_abnormal_cardiac_muscle | 4.47221532 |
| 8 | MP0004215_abnormal_myocardial_fiber | 3.71449546 |
| 9 | MP0004087_abnormal_muscle_fiber | 3.39079525 |
| 10 | MP0002106_abnormal_muscle_physiology | 3.38276663 |
| 11 | MP0005330_cardiomyopathy | 3.25901966 |
| 12 | MP0000747_muscle_weakness | 3.16196729 |
| 13 | MP0000750_abnormal_muscle_regeneration | 3.11380465 |
| 14 | MP0005620_abnormal_muscle_contractility | 3.06071227 |
| 15 | MP0004130_abnormal_muscle_cell | 2.97941009 |
| 16 | MP0002269_muscular_atrophy | 2.92265640 |
| 17 | MP0000759_abnormal_skeletal_muscle | 2.85723609 |
| 18 | MP0005369_muscle_phenotype | 2.79022484 |
| 19 | MP0002972_abnormal_cardiac_muscle | 2.55593445 |
| 20 | MP0004233_abnormal_muscle_weight | 2.29541633 |
| 21 | MP0003137_abnormal_impulse_conducting | 2.22263459 |
| 22 | MP0008775_abnormal_heart_ventricle | 2.19592055 |
| 23 | MP0010630_abnormal_cardiac_muscle | 2.16046637 |
| 24 | MP0004484_altered_response_of | 2.07469065 |
| 25 | MP0005385_cardiovascular_system_phenoty | 2.04194770 |
| 26 | MP0001544_abnormal_cardiovascular_syste | 2.04194770 |
| 27 | MP0002332_abnormal_exercise_endurance | 1.88617960 |
| 28 | MP0006036_abnormal_mitochondrial_physio | 1.84219838 |
| 29 | MP0006138_congestive_heart_failure | 1.70304018 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.68142092 |
| 31 | MP0005666_abnormal_adipose_tissue | 1.51478604 |
| 32 | MP0004085_abnormal_heartbeat | 1.51364744 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.48611818 |
| 34 | MP0003828_pulmonary_edema | 1.45360020 |
| 35 | MP0002108_abnormal_muscle_morphology | 1.43615541 |
| 36 | MP0000733_abnormal_muscle_development | 1.34653864 |
| 37 | MP0004510_myositis | 1.33812222 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.30210962 |
| 39 | MP0002127_abnormal_cardiovascular_syste | 1.26754681 |
| 40 | MP0002234_abnormal_pharynx_morphology | 1.17564486 |
| 41 | MP0005670_abnormal_white_adipose | 1.12986193 |
| 42 | MP0005375_adipose_tissue_phenotype | 1.07238591 |
| 43 | MP0001661_extended_life_span | 1.06818547 |
| 44 | MP0006035_abnormal_mitochondrial_morpho | 1.02761817 |
| 45 | MP0000343_altered_response_to | 0.96389986 |
| 46 | MP0000266_abnormal_heart_morphology | 0.93287560 |
| 47 | MP0005266_abnormal_metabolism | 0.93251611 |
| 48 | MP0002971_abnormal_brown_adipose | 0.90902304 |
| 49 | MP0003705_abnormal_hypodermis_morpholog | 0.83458797 |
| 50 | MP0003567_abnormal_fetal_cardiomyocyte | 0.83088380 |
| 51 | MP0005275_abnormal_skin_tensile | 0.81556229 |
| 52 | MP0000013_abnormal_adipose_tissue | 0.78985709 |
| 53 | MP0000372_irregular_coat_pigmentation | 0.75724717 |
| 54 | MP0003806_abnormal_nucleotide_metabolis | 0.72220910 |
| 55 | MP0005165_increased_susceptibility_to | 0.71422828 |
| 56 | MP0004043_abnormal_pH_regulation | 0.66400942 |
| 57 | MP0000230_abnormal_systemic_arterial | 0.65560504 |
| 58 | MP0003279_aneurysm | 0.65406362 |
| 59 | MP0003879_abnormal_hair_cell | 0.63361090 |
| 60 | MP0000003_abnormal_adipose_tissue | 0.62235589 |
| 61 | MP0010368_abnormal_lymphatic_system | 0.60183109 |
| 62 | MP0004147_increased_porphyrin_level | 0.59367043 |
| 63 | MP0002128_abnormal_blood_circulation | 0.58097760 |
| 64 | MP0004134_abnormal_chest_morphology | 0.57603921 |
| 65 | MP0008961_abnormal_basal_metabolism | 0.55238861 |
| 66 | MP0002909_abnormal_adrenal_gland | 0.52892586 |
| 67 | MP0002078_abnormal_glucose_homeostasis | 0.52645403 |
| 68 | MP0004142_abnormal_muscle_tone | 0.50395307 |
| 69 | MP0002638_abnormal_pupillary_reflex | 0.45456871 |
| 70 | MP0001879_abnormal_lymphatic_vessel | 0.44790294 |
| 71 | MP0003566_abnormal_cell_adhesion | 0.42424530 |
| 72 | MP0004270_analgesia | 0.41857177 |
| 73 | MP0005623_abnormal_meninges_morphology | 0.41202265 |
| 74 | MP0008569_lethality_at_weaning | 0.41011820 |
| 75 | MP0005334_abnormal_fat_pad | 0.40936847 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 0.40356716 |
| 77 | MP0005423_abnormal_somatic_nervous | 0.38642411 |
| 78 | MP0002734_abnormal_mechanical_nocicepti | 0.38332167 |
| 79 | MP0009672_abnormal_birth_weight | 0.38299021 |
| 80 | MP0001346_abnormal_lacrimal_gland | 0.37322785 |
| 81 | MP0005451_abnormal_body_composition | 0.36281913 |
| 82 | MP0010030_abnormal_orbit_morphology | 0.34433406 |
| 83 | MP0005166_decreased_susceptibility_to | 0.34134912 |
| 84 | MP0005187_abnormal_penis_morphology | 0.34119953 |
| 85 | MP0003045_fibrosis | 0.33662356 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.33172256 |
| 87 | MP0002114_abnormal_axial_skeleton | 0.33159787 |
| 88 | MP0003948_abnormal_gas_homeostasis | 0.33027976 |
| 89 | MP0008438_abnormal_cutaneous_collagen | 0.32846623 |
| 90 | MP0005535_abnormal_body_temperature | 0.32157959 |
| 91 | MP0000767_abnormal_smooth_muscle | 0.32136303 |
| 92 | MP0000579_abnormal_nail_morphology | 0.31304766 |
| 93 | MP0001299_abnormal_eye_distance/ | 0.31152650 |
| 94 | MP0002925_abnormal_cardiovascular_devel | 0.29991059 |
| 95 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.29734694 |
| 96 | MP0009115_abnormal_fat_cell | 0.28114671 |
| 97 | MP0005452_abnormal_adipose_tissue | 0.28052952 |
| 98 | MP0000762_abnormal_tongue_morphology | 0.27860945 |
| 99 | MP0005332_abnormal_amino_acid | 0.27302073 |
| 100 | MP0009250_abnormal_appendicular_skeleto | 0.26830682 |
| 101 | MP0009780_abnormal_chondrocyte_physiolo | 0.26378824 |
| 102 | MP0001784_abnormal_fluid_regulation | 0.25249920 |
| 103 | MP0006276_abnormal_autonomic_nervous | 0.24970370 |
| 104 | MP0002090_abnormal_vision | 0.24953753 |
| 105 | MP0002822_catalepsy | 0.24371850 |
| 106 | MP0002896_abnormal_bone_mineralization | 0.24039587 |
| 107 | MP0002066_abnormal_motor_capabilities/c | 0.23543133 |
| 108 | MP0001614_abnormal_blood_vessel | 0.23339931 |
| 109 | MP0001943_abnormal_respiration | 0.22491320 |
| 110 | MP0004272_abnormal_basement_membrane | 0.22205265 |
| 111 | MP0002118_abnormal_lipid_homeostasis | 0.21100160 |
| 112 | MP0002876_abnormal_thyroid_physiology | 0.20323722 |
| 113 | MP0002067_abnormal_sensory_capabilities | 0.18653981 |
| 114 | MP0009384_cardiac_valve_regurgitation | 0.18207566 |
| 115 | MP0001853_heart_inflammation | 0.18097022 |
| 116 | MP0005645_abnormal_hypothalamus_physiol | 0.17866945 |
| 117 | MP0005376_homeostasis/metabolism_phenot | 0.17828119 |
| 118 | MP0003959_abnormal_lean_body | 0.17668431 |
| 119 | MP0005595_abnormal_vascular_smooth | 0.17164839 |
| 120 | MP0005386_behavior/neurological_phenoty | 0.17064123 |
| 121 | MP0004924_abnormal_behavior | 0.17064123 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.17057670 |
| 123 | MP0005503_abnormal_tendon_morphology | 0.16971633 |
| 124 | MP0005083_abnormal_biliary_tract | 0.16237482 |
| 125 | MP0004858_abnormal_nervous_system | 0.12065673 |
| 126 | MP0008874_decreased_physiological_sensi | 0.11742980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Exercise-induced myalgia (HP:0003738) | 7.14586218 |
| 2 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.03570382 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 6.95509817 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 6.73651459 |
| 5 | * Exercise-induced muscle cramps (HP:0003710) | 6.60204126 |
| 6 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.54233412 |
| 7 | Muscle fiber splitting (HP:0003555) | 6.13544374 |
| 8 | Sudden death (HP:0001699) | 6.09919492 |
| 9 | Nemaline bodies (HP:0003798) | 5.85651098 |
| 10 | Type 1 muscle fiber predominance (HP:0003803) | 5.52518232 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 5.46340188 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 5.28211492 |
| 13 | Difficulty running (HP:0009046) | 5.05961942 |
| 14 | * Myoglobinuria (HP:0002913) | 5.04303325 |
| 15 | Ventricular tachycardia (HP:0004756) | 4.90562967 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 4.89731273 |
| 17 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.80182992 |
| 18 | Subaortic stenosis (HP:0001682) | 4.80182992 |
| 19 | Distal arthrogryposis (HP:0005684) | 4.79283864 |
| 20 | Increased connective tissue (HP:0009025) | 4.71590877 |
| 21 | Myopathic facies (HP:0002058) | 4.34040812 |
| 22 | Myotonia (HP:0002486) | 4.24307674 |
| 23 | Round ear (HP:0100830) | 4.21461998 |
| 24 | Muscle stiffness (HP:0003552) | 4.03336372 |
| 25 | Atrial fibrillation (HP:0005110) | 3.93375189 |
| 26 | Lipoatrophy (HP:0100578) | 3.84567326 |
| 27 | Asymmetric septal hypertrophy (HP:0001670) | 3.81894047 |
| 28 | * Rhabdomyolysis (HP:0003201) | 3.81261705 |
| 29 | Ulnar deviation of the wrist (HP:0003049) | 3.75673914 |
| 30 | Primary atrial arrhythmia (HP:0001692) | 3.66719405 |
| 31 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.54180495 |
| 32 | Supraventricular tachycardia (HP:0004755) | 3.54012760 |
| 33 | Difficulty climbing stairs (HP:0003551) | 3.52464842 |
| 34 | Right ventricular cardiomyopathy (HP:0011663) | 3.48200193 |
| 35 | Supraventricular arrhythmia (HP:0005115) | 3.46595763 |
| 36 | Increased variability in muscle fiber diameter (HP:0003557) | 3.42835574 |
| 37 | Dilated cardiomyopathy (HP:0001644) | 3.35668152 |
| 38 | Neck muscle weakness (HP:0000467) | 3.30301107 |
| 39 | Bundle branch block (HP:0011710) | 3.27098704 |
| 40 | Palpitations (HP:0001962) | 3.13741331 |
| 41 | Rimmed vacuoles (HP:0003805) | 3.08824336 |
| 42 | Calcaneovalgus deformity (HP:0001848) | 3.08700011 |
| 43 | Prolonged QT interval (HP:0001657) | 3.07383211 |
| 44 | Syncope (HP:0001279) | 3.06357374 |
| 45 | Areflexia of lower limbs (HP:0002522) | 3.04736333 |
| 46 | Ventricular arrhythmia (HP:0004308) | 2.91826544 |
| 47 | Absent phalangeal crease (HP:0006109) | 2.87323116 |
| 48 | Deformed tarsal bones (HP:0008119) | 2.86992640 |
| 49 | Distal lower limb muscle weakness (HP:0009053) | 2.78282125 |
| 50 | Heart block (HP:0012722) | 2.77038694 |
| 51 | Fetal akinesia sequence (HP:0001989) | 2.65822021 |
| 52 | Slender build (HP:0001533) | 2.61869990 |
| 53 | Abnormal atrioventricular conduction (HP:0005150) | 2.61673587 |
| 54 | Frequent falls (HP:0002359) | 2.61438935 |
| 55 | Ventricular fibrillation (HP:0001663) | 2.56459121 |
| 56 | Limb-girdle muscle atrophy (HP:0003797) | 2.54134054 |
| 57 | Atrioventricular block (HP:0001678) | 2.52626691 |
| 58 | EMG: neuropathic changes (HP:0003445) | 2.46484531 |
| 59 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.43179150 |
| 60 | Muscular dystrophy (HP:0003560) | 2.41451656 |
| 61 | Abnormality of the calcaneus (HP:0008364) | 2.41386730 |
| 62 | Abnormal finger flexion creases (HP:0006143) | 2.35093341 |
| 63 | Hypoplastic ischia (HP:0003175) | 2.34452273 |
| 64 | Malignant hyperthermia (HP:0002047) | 2.31956711 |
| 65 | Generalized muscle weakness (HP:0003324) | 2.31165543 |
| 66 | Abnormal EKG (HP:0003115) | 2.25341276 |
| 67 | Gowers sign (HP:0003391) | 2.23929901 |
| 68 | Left ventricular hypertrophy (HP:0001712) | 2.23574684 |
| 69 | Facial diplegia (HP:0001349) | 2.22426107 |
| 70 | Hip contracture (HP:0003273) | 2.21458151 |
| 71 | Scapular winging (HP:0003691) | 2.17095672 |
| 72 | Distal lower limb amyotrophy (HP:0008944) | 2.16359376 |
| 73 | Hyperkalemia (HP:0002153) | 2.13838345 |
| 74 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.13756457 |
| 75 | Proximal amyotrophy (HP:0007126) | 2.11464785 |
| 76 | Waddling gait (HP:0002515) | 2.10807210 |
| 77 | Abnormality of the neuromuscular junction (HP:0003398) | 2.10054475 |
| 78 | Fatigable weakness (HP:0003473) | 2.10054475 |
| 79 | Limb-girdle muscle weakness (HP:0003325) | 2.06608487 |
| 80 | Abnormality of the ischium (HP:0003174) | 2.03254852 |
| 81 | Lower limb amyotrophy (HP:0007210) | 2.00064819 |
| 82 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.99717412 |
| 83 | Ketoacidosis (HP:0001993) | 1.98320247 |
| 84 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.97605305 |
| 85 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.97605305 |
| 86 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.96477247 |
| 87 | Bulbar palsy (HP:0001283) | 1.95699983 |
| 88 | Palmoplantar keratoderma (HP:0000982) | 1.95414167 |
| 89 | Spinal rigidity (HP:0003306) | 1.95180697 |
| 90 | Hepatic necrosis (HP:0002605) | 1.94741791 |
| 91 | Increased muscle lipid content (HP:0009058) | 1.94331805 |
| 92 | Shoulder girdle muscle weakness (HP:0003547) | 1.91527245 |
| 93 | Pelvic girdle muscle weakness (HP:0003749) | 1.91457127 |
| 94 | Exercise intolerance (HP:0003546) | 1.90757053 |
| 95 | Testicular atrophy (HP:0000029) | 1.88485867 |
| 96 | Progressive muscle weakness (HP:0003323) | 1.86261918 |
| 97 | Abnormality of the foot musculature (HP:0001436) | 1.86247493 |
| 98 | Acute necrotizing encephalopathy (HP:0006965) | 1.85462674 |
| 99 | Foot dorsiflexor weakness (HP:0009027) | 1.83596452 |
| 100 | Central scotoma (HP:0000603) | 1.83154270 |
| 101 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.82398305 |
| 102 | Conjunctival hamartoma (HP:0100780) | 1.81316964 |
| 103 | Long clavicles (HP:0000890) | 1.81036379 |
| 104 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.78071611 |
| 105 | Ragged-red muscle fibers (HP:0003200) | 1.76653324 |
| 106 | Cholelithiasis (HP:0001081) | 1.76648508 |
| 107 | Paralysis (HP:0003470) | 1.75730547 |
| 108 | Weak cry (HP:0001612) | 1.75439422 |
| 109 | Nonprogressive disorder (HP:0003680) | 1.72608691 |
| 110 | Hepatocellular necrosis (HP:0001404) | 1.72600466 |
| 111 | Increased intramyocellular lipid droplets (HP:0012240) | 1.69850132 |
| 112 | Metatarsus adductus (HP:0001840) | 1.68977577 |
| 113 | Popliteal pterygium (HP:0009756) | 1.68482265 |
| 114 | Type 2 muscle fiber atrophy (HP:0003554) | 1.62623742 |
| 115 | Ulnar deviation of finger (HP:0009465) | 1.59237092 |
| 116 | Oligomenorrhea (HP:0000876) | 1.51114902 |
| 117 | Muscle fiber atrophy (HP:0100295) | 1.49196010 |
| 118 | Limited hip movement (HP:0008800) | 1.47070046 |
| 119 | Steppage gait (HP:0003376) | 1.38672772 |
| 120 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.34345758 |
| 121 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.29395204 |
| 122 | Congenital hip dislocation (HP:0001374) | 1.24925763 |
| 123 | Abnormality of potassium homeostasis (HP:0011042) | 1.24526710 |
| 124 | Adducted thumb (HP:0001181) | 1.23217675 |
| 125 | Easy fatigability (HP:0003388) | 1.20171029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.98109166 |
| 2 | TTN | 6.91964206 |
| 3 | * PHKG1 | 3.16301241 |
| 4 | * PHKG2 | 3.16301241 |
| 5 | PDK3 | 3.09206972 |
| 6 | PDK4 | 3.09206972 |
| 7 | DMPK | 2.82566776 |
| 8 | NEK1 | 2.78917791 |
| 9 | TRIB3 | 2.67019907 |
| 10 | PINK1 | 2.49084169 |
| 11 | NME1 | 2.48386351 |
| 12 | LMTK2 | 2.45683422 |
| 13 | PIK3CA | 2.30403662 |
| 14 | BCKDK | 2.29300347 |
| 15 | MUSK | 2.27152654 |
| 16 | PKN2 | 2.25468602 |
| 17 | MYLK | 2.20716684 |
| 18 | PIK3CG | 2.07314360 |
| 19 | MAP2K3 | 1.98602644 |
| 20 | PDK2 | 1.91246222 |
| 21 | MAP3K7 | 1.85874881 |
| 22 | MAPK12 | 1.52736402 |
| 23 | TIE1 | 1.51071189 |
| 24 | STK24 | 1.45708249 |
| 25 | MARK1 | 1.11488750 |
| 26 | RIPK1 | 1.03634273 |
| 27 | PRKAA1 | 1.02872197 |
| 28 | MAPKAPK3 | 0.99423614 |
| 29 | PRKAA2 | 0.98771151 |
| 30 | CCNB1 | 0.97006639 |
| 31 | LIMK1 | 0.95191735 |
| 32 | PRKD1 | 0.94497801 |
| 33 | ILK | 0.93573434 |
| 34 | MOS | 0.93020254 |
| 35 | MAP2K4 | 0.90832997 |
| 36 | CAMK2D | 0.90164740 |
| 37 | GRK7 | 0.85073695 |
| 38 | MAP2K6 | 0.83728386 |
| 39 | MAP3K3 | 0.83218394 |
| 40 | PAK3 | 0.80177464 |
| 41 | TRPM7 | 0.79994647 |
| 42 | ZAK | 0.79991042 |
| 43 | DYRK1B | 0.79215165 |
| 44 | ROCK1 | 0.76984324 |
| 45 | MAP3K13 | 0.69577961 |
| 46 | MAP3K5 | 0.68257303 |
| 47 | INSRR | 0.67485734 |
| 48 | EPHB1 | 0.65375294 |
| 49 | NEK9 | 0.64310672 |
| 50 | FLT3 | 0.63935390 |
| 51 | PKN1 | 0.60591736 |
| 52 | STK38 | 0.57412294 |
| 53 | SIK1 | 0.55016137 |
| 54 | CAMK2G | 0.54344406 |
| 55 | AKT2 | 0.53211751 |
| 56 | STK38L | 0.50321420 |
| 57 | TGFBR2 | 0.48185497 |
| 58 | CDC42BPA | 0.47773323 |
| 59 | CAMK4 | 0.46397410 |
| 60 | ROCK2 | 0.45620720 |
| 61 | TAOK1 | 0.44753758 |
| 62 | CAMK2B | 0.44650558 |
| 63 | TAOK2 | 0.42974457 |
| 64 | MAPK11 | 0.42943617 |
| 65 | PDGFRA | 0.42609077 |
| 66 | PTK6 | 0.41140411 |
| 67 | PRKACA | 0.38883729 |
| 68 | WNK1 | 0.38795719 |
| 69 | CAMK1 | 0.38260137 |
| 70 | MAPK13 | 0.38188046 |
| 71 | SGK2 | 0.37910155 |
| 72 | CAMK2A | 0.37541483 |
| 73 | PDPK1 | 0.35118065 |
| 74 | * PRKACB | 0.34575966 |
| 75 | TBK1 | 0.33784728 |
| 76 | SGK1 | 0.32562360 |
| 77 | MAP3K11 | 0.32514194 |
| 78 | PAK6 | 0.32339628 |
| 79 | WNK4 | 0.32092431 |
| 80 | ICK | 0.31043518 |
| 81 | PRKG1 | 0.30989483 |
| 82 | DAPK2 | 0.30818769 |
| 83 | PRKACG | 0.30474149 |
| 84 | STK4 | 0.29996317 |
| 85 | RPS6KB1 | 0.29387288 |
| 86 | PDK1 | 0.29281674 |
| 87 | RPS6KC1 | 0.28651080 |
| 88 | RPS6KL1 | 0.28651080 |
| 89 | CDK19 | 0.28322966 |
| 90 | PTK2B | 0.27905895 |
| 91 | DAPK3 | 0.27891898 |
| 92 | MAP3K1 | 0.26917926 |
| 93 | RPS6KA3 | 0.26644945 |
| 94 | MAPK7 | 0.26531608 |
| 95 | PRKCH | 0.26073014 |
| 96 | MAPK10 | 0.25117016 |
| 97 | PRKD3 | 0.24450994 |
| 98 | KDR | 0.24402553 |
| 99 | FER | 0.22818091 |
| 100 | MARK2 | 0.22578289 |
| 101 | RPS6KA6 | 0.22005776 |
| 102 | SGK3 | 0.21309868 |
| 103 | RPS6KA1 | 0.21056602 |
| 104 | EEF2K | 0.18241892 |
| 105 | RPS6KB2 | 0.18153102 |
| 106 | RET | 0.18011703 |
| 107 | SGK494 | 0.17955665 |
| 108 | SGK223 | 0.17955665 |
| 109 | MTOR | 0.16997994 |
| 110 | CAMK1G | 0.16681619 |
| 111 | STK11 | 0.16229541 |
| 112 | LATS1 | 0.15892277 |
| 113 | ARAF | 0.15668735 |
| 114 | MARK3 | 0.15117734 |
| 115 | PRKCE | 0.15084736 |
| 116 | NLK | 0.14320308 |
| 117 | KSR2 | 0.13364681 |
| 118 | LATS2 | 0.13343079 |
| 119 | ZAP70 | 0.12257937 |
| 120 | LRRK2 | 0.11248246 |
| 121 | PRPF4B | 0.11048809 |
| 122 | MAPK4 | 0.10855400 |
| 123 | ERBB3 | 0.10677536 |
| 124 | RAF1 | 0.10556379 |
| 125 | MAP2K1 | 0.10377292 |
| 126 | TNK2 | 0.09208710 |
| 127 | EPHA3 | 0.08874319 |
| 128 | KSR1 | 0.05259182 |
| 129 | MAP2K2 | 0.04932004 |
| 130 | MAPK9 | 0.04470582 |
| 131 | MAP3K10 | 0.04338597 |
| 132 | GSK3B | 0.04336098 |
| 133 | MAPK8 | 0.04144461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.53527274 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.18696413 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.15401643 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.01297809 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.83828611 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.05553505 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.00809102 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.91835907 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.51714161 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.44841810 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43578955 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.32703703 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 1.99400345 |
| 14 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.91807920 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.90013276 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87148594 |
| 17 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.79170453 |
| 18 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.65908709 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.64686164 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.59123667 |
| 21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.38049203 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.35573933 |
| 23 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.30899340 |
| 24 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.30834366 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.30477237 |
| 26 | * Insulin resistance_Homo sapiens_hsa04931 | 1.26494519 |
| 27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.25251401 |
| 28 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 1.25211303 |
| 29 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.23306948 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.22585145 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.17195130 |
| 32 | Circadian rhythm_Homo sapiens_hsa04710 | 1.16455890 |
| 33 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.11208504 |
| 34 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.10089788 |
| 35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.04447332 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.98624992 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.97174122 |
| 38 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.96263702 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93963587 |
| 40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92200935 |
| 41 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86947293 |
| 42 | Focal adhesion_Homo sapiens_hsa04510 | 0.83766214 |
| 43 | Long-term potentiation_Homo sapiens_hsa04720 | 0.82690697 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80741777 |
| 45 | Tight junction_Homo sapiens_hsa04530 | 0.80678688 |
| 46 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.78017534 |
| 47 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.76968328 |
| 48 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.76188490 |
| 49 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.73755273 |
| 50 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.73105366 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70799241 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.69745391 |
| 53 | Renin secretion_Homo sapiens_hsa04924 | 0.69258677 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66604238 |
| 55 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60378459 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.59413936 |
| 57 | Insulin secretion_Homo sapiens_hsa04911 | 0.57428786 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.51949599 |
| 59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51660932 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50444528 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47794417 |
| 62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46515538 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.46036748 |
| 64 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.45209292 |
| 65 | Long-term depression_Homo sapiens_hsa04730 | 0.45156702 |
| 66 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.44126399 |
| 67 | Circadian entrainment_Homo sapiens_hsa04713 | 0.43609525 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42935175 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42767418 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41659752 |
| 71 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.40986928 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40960518 |
| 73 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39044630 |
| 74 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38842705 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37959769 |
| 76 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.37468373 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35362021 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.34746418 |
| 79 | Adherens junction_Homo sapiens_hsa04520 | 0.33919196 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.32786217 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.30279801 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29580414 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.29418758 |
| 84 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.29381924 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.28035710 |
| 86 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.27084960 |
| 87 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.26628668 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26346672 |
| 89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.24391249 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23783847 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22998570 |
| 92 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.22839947 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22664966 |
| 94 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.21915311 |
| 95 | Purine metabolism_Homo sapiens_hsa00230 | 0.20093011 |
| 96 | Salivary secretion_Homo sapiens_hsa04970 | 0.19138854 |
| 97 | Olfactory transduction_Homo sapiens_hsa04740 | 0.18552777 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.18067338 |
| 99 | Phototransduction_Homo sapiens_hsa04744 | 0.14788531 |
| 100 | Gap junction_Homo sapiens_hsa04540 | 0.14717726 |
| 101 | Melanogenesis_Homo sapiens_hsa04916 | 0.14531808 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13978070 |
| 103 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.13448680 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.13425288 |
| 105 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.12568515 |
| 106 | Bile secretion_Homo sapiens_hsa04976 | 0.12041289 |
| 107 | GABAergic synapse_Homo sapiens_hsa04727 | 0.11850569 |
| 108 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.10886722 |
| 109 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.10180945 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.10146213 |
| 111 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.09951975 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.09524019 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08506401 |
| 114 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.08228974 |
| 115 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.08006683 |
| 116 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.07648216 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.07441969 |
| 118 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.06922215 |

